Related Experiment Video
Updated: Aug 11, 2026
12:35
Comparison of Three Different Methods for Determining Cell Proliferation in Breast Cancer Cell Lines
Published on: September 3, 2016
Proliferation measurement in breast cancer by two different methods
Fernando Martínez-Arribas1, Elena Martín-Garabato, Pilar Lafuente
1Fundación Tejerina-Centro de Patología de la Mama, Madrid.
Anticancer Research
|February 16, 2006
Summary
Ki67 immunohistochemistry is a simple, reliable method for measuring breast cancer proliferation, outperforming flow cytometry in cost and ease of use. This study compared proliferation measurement techniques for prognostic value in breast cancer.
Area of Science:
- Oncology
- Biomarkers
- Cancer Research
Background:
- Tumor proliferation is a key prognostic indicator in breast cancer.
- Accurate measurement of proliferation is crucial for treatment decisions.
- Comparing different measurement techniques is essential for clinical utility.
Purpose of the Study:
- To compare immunohistochemistry (Ki67) and flow cytometry for breast cancer proliferation assessment.
- To determine which method better discriminates between high and low proliferation tumors.
- To evaluate proliferation measurement in relation to clinical and biological parameters.
Main Methods:
- Studied 280 breast cancer cases with varying subtypes and stages.
- Assessed proliferation using flow cytometry (DNA index, S-phase) and immunohistochemistry (Ki67).
- Analyzed hormone receptor status (ER, PR), c-erb-B2, p53 expression, histological grade, nuclear grade, tumor size, and nodal invasion.
Main Results:
- Ki67 expression (≥20%) strongly correlated with high-grade tumors, absence of hormone receptors, c-erb-B2, p53 expression, and larger tumor size.
- Flow cytometry (aneuploidy) also correlated with high-grade tumors, absence of hormone receptors, c-erb-B2, p53 expression, and nodal invasion.
- Ki67 did not correlate with nodal invasion, while flow cytometry did.
Conclusions:
- Ki67 immunohistochemistry is a simple, cost-effective, and reliable method for assessing breast cancer proliferation.
- Flow cytometry provides additional prognostic data, specifically regarding nodal invasion.
- Ki67 emerges as a preferred method for routine clinical assessment of breast cancer proliferation.
